U.S. imports of Penicillins, Streptomycins & Derivatives in Dosage Form (HS 300410) totaled $34.8M in August 2026, imported from 16 countries.
Last updated: August 2026 dataFinished-dose penicillin and streptomycin antibiotic products — including amoxicillin oral suspensions, piperacillin-tazobactam combinations, and veterinary formulations — are classified across eleven 10-digit tariff lines under this heading, reflecting the commercial diversity of the beta-lactam antibiotic market. India is the leading US supplier, consistent with its dominant role in global generic antibiotic manufacturing, with Italy, China, Jordan, and Canada also contributing. All finished pharmaceutical imports require FDA review; veterinary formulations (e.g., 3004101010) additionally fall under USDA oversight for animal drug approvals. Combination products containing piperacillin and tazobactam have their own dedicated line (3004105048), signaling the commercial significance of that hospital-critical drug.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
243 import shipments a month
Veterinary penicillin formulations must comply with FDA Center for Veterinary Medicine (CVM) approval requirements in addition to standard pharmaceutical import procedures. The foreign manufacturer must hold an approved New Animal Drug Application (NADA) or abbreviated NADA, and the product must be labeled for veterinary use. Human-use formulations follow the Center for Drug Evaluation and Research (CDER) pathway instead.
The US schedule carved out a specific line for piperacillin-tazobactam combination antibiotics due to their clinical importance as a hospital-critical, last-resort antibiotic and the trade monitoring interest that follows. Having a dedicated line allows CBP and FDA to track import volumes and sources for this specific combination independently of other penicillin combinations, which is relevant for supply-chain resilience planning.
Subheading 7 of 12 in heading 3004
Subheading 300410 · $34.8M of $7.1B
ImportsExports
Imports
$34.8MYoY · free account
Exports
$1.7MYoY · free account
12-mo low · imports
Low · free accountOver the twelve months to August 2026, the U.S. imported $376.5M of Penicillins, Streptomycins & Derivatives in Dosage Form and exported $31.1M.
Through August 2026. Source: U.S. Census Bureau.
Trade Directory
List your company under HS 300410 — Penicillins, Streptomycins & Derivatives in Dosage Form, so the companies trading it can find you. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Imports for consumption | Average duty rate | Dutiable Share |
|---|---|---|---|---|
| 3004105010 | Medicaments Containing Penicillins or Deriv Etc | $9.9M | 0.00% | 0.00% |
| 3004105048 | Combo Antibtcs Cntning Piperacillin and Tazobactam | $9.6M | 0.00% | 0.00% |
| 3004105065 | Containing Amoxicillin or Its Salts, NESOI | $8.6M | 0.00% | 0.00% |
| 3004101020 | Penicillin G Salts(Singles) not for Veterinary Use | $2.3M | 0.00% | 0.00% |
| 3004105049 | Combination Antibiotics Contain Penicillin, NESOI | $2.1M | 0.00% | 0.00% |
| 3004105055 | Containing Amoxicillin or Its Salts, Oral Suspenion | $2.3M | 0.00% | 0.00% |
| 3004105080 | Combination Antibiotics, NESOI | $1.3M | 0.00% | 0.00% |
| 3004105070 | Containing Ampicillin or Its Salts | $880K | 0.00% | 0.00% |
| 3004101010 | Medicaments Cont Penicillin G Slts for Vetrin Use | $38K | 0.00% | 0.00% |
| 3004105045 | Combination Antibiotics Contain Penicillin, NESOI | — | -- | -- |
| 3004101045 | Combination Antibiotics Containing Penicillin G | — | -- | -- |
| 3004105075 | Combination Antibiotics, NESOI | — | -- | -- |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
Imports · August 2026
origin
India and Italy together supply 77% of it.
customs district
destination
entry
rate provision · imports
88.5% enters free of duty; duty collected equals 0.00% of imports for consumption.